Aurinia Pharmaceuticals (AUPH) Return on Capital Employed Growth (3y) (2024 - 2026)
Aurinia Pharmaceuticals (AUPH) Return on Capital Employed Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 4,853.00 |
| 10 | Aurinia Pharmaceuticals | 2.05 Bn | 1.67 Bn | 71.20 Mn | 4,372.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,372.00 |
| Dec 31, 2025 | 4,494.00 |
| Sep 30, 2025 | 4,213.00 |
| Jun 30, 2025 | 4,635.00 |
| Mar 31, 2025 | 4,083.00 |
| Dec 31, 2024 | 4,293.00 |
| Sep 30, 2024 | 3,936.00 |
| Jun 30, 2024 | 2,606.00 |
| Mar 31, 2024 | 1,414.00 |